Dendritic cell vaccine

According to many clinical studies, Dendritic cells (DCs) have unique characteristics that have made them an ideal choice for anti-tumor vaccines.

They are considered to be the most effective antigen-presenting cell that is responsible for primarily sensitizing naive T-cells to a specific antigen. DCs are ten to 100 times more potent than B cells and monocytes. In addition, DCs play an important role in the establishment of immunologic memory which is a key factory to the anti-cancer efficiency.

In contrast with monocytes and B cells, DCs has the capacity to use soluble protein antigens to sensitize naive T-cells in vitro. Using these soluble proteins, DCs have successfully sensitized both CD8 and CD4that are T-cells inducing antigen-specific cytotoxic T lymphocytes.

According to many clinical studies, Dendritic cells (DCs) have unique characteristics that have made them an ideal choice for anti-tumor vaccines.

The above ability gives scientists developing these DC-based vaccines a variation of potential antigen agents that are highly effective in sensitizing T-cells. With regards to fighting cancer, there are many testimonies and evidence-based studies that prove the ability of DCs on being one of the key success factor in destroying tumor cells.

Benefits DC vaccine

Generally, dendritic cell therapy can bring about the following benefits and further boost anti-cancer functions:

• Boosting of immunity
• Enhancing the migration function of the T-cells
• Increase the longevity of the T-cells
• Improve cytokine creation

The treatment

In this treatment, the patient’s blood will firstly be extracted followed by the cells. These cells are then cultured into DC and different types of cancer antigens are then added to a vaccine that has anti-cancer properties.

The DC vaccine is injected or reintroduced into the body helps boost the immune function. The T cells are able to better detect and destroy cancer cells. It has the ability to teach the white blood cells to recognize and defeat these cancer cells and pathogens making Dendritic cell or DC vaccine a formidable asset in the fight against cancer.